Skip to main content
Malaysian Orthopaedic Journal logoLink to Malaysian Orthopaedic Journal
. 2023 Mar;17(1):10–17. doi: 10.5704/MOJ.2303.002

Pre-operative Factors Predicting Mortality in Six Months and Functional Recovery in Elderly Patients with Hip Fractures

NH Nam 1, ND Minh 2, TX Hai 3, CT Sinh 4, CB Loi 5, LT Anh 6,
PMCID: PMC10103916  PMID: 37064636

Abstract

Introduction

This study aimed to determine on-admission and perioperative factors predicting six-month mortality and functional recovery in Vietnamese patients with hip fracture.

Materials and methods

Between April 2020 and July 2021, 118 patients participated in this prospective study. Patients’ data were collected from medical records. Harris hip score (HHS) was used to evaluate the functional recovery six months after fractures. The obtained data were analysed using a univariate and multivariate model.

Results

The mean age of the participants was 79.5±9.4 years and 68.6% of the patients were female. The six-month mortality rate was 5.9% and independently associated with age (odds ratio (OR): 3.512, 95% confidence interval (CI) 1.538 – 8.019; P<0.001, patients aged >80 years vs those aged ≤80 years) and hypoproteinemia (OR: 2.859, 95% CI: 1.001 – 8.166, P=0.049). Among 111 survivors there were 66 (59.5%) of patients with a good functional recovery. Patients aged >80 years had a higher risk of poor functional outcome (OR: 3.167, 95% CI: 1.386 – 7.235, P: 0.006) compared to those aged ≤ 80 years. No significant correlations between other clinical (gender, body mass index, comorbidities, type of fractures or surgery, time until surgery) or laboratory parameters (anaemia, hyperglycemia, marked elevation of C reactive protein level, electrolyte abnormalities, elevated urea) and mortality or functional outcome were found.

Conclusion

Advanced age is the most important factor affecting both mortality and functional outcome while hypoproteinemia is associated with a higher risk of mortality in elderly patients with hip fractures.

Keywords: hip fracture, mortality, functional recovery, harris hip score, Vietnam

Introduction

Hip fractures are breaks of the upper portion of the femur (thigh bone) which are estimated to affect about 18% of women and 6% of men worldwide1. This devastating injury commonly occurs in the elderly and put patients at an increased risk of adverse outcomes, such as early death or functional decline. The first six months post-fracture is the most critical time as the risk of mortality is the highest and functional recovery occurs mostly between three and six months after fractures2-5. Thus, understanding the factors predicting six-month mortality and the functional recovery has become a central issue and received considerable attention. However, most data in this field have been from Western developed nations, and little is known about factors related to short-term mortality and functional recovery of hip fracture patients in Asian countries6.

Vietnam is a Southeast Asia country with a rapidly ageing population7. It is predicted that more than one-quarter of the total population aged over 60 years old by 20497. As a result of the rapid increase in the elderly population, the number of hip fracture patients is also expected to increase. Compared to hip fracture patients from developed nation, Vietnamese patients have different demographic or clinical characteristics8-10. Consequently, the factors correlated to mortality or functional outcome among hip fracture patients may be different from those in developed countries. For this reason, the data from Vietnam are useful for clinical implementation and further scientific understanding as well. As far as we know, no previous research has directly investigated this topic in Vietnam10,11.

The objectives of this research were to determine whether any on-admission and perioperative factors, especially manageable ones, were associated with six-month mortality and functional outcome in a Vietnamese cohort.

Materials and Methods

This study is part of thesis work for the fulfilment of Doctor of Philosophy in Health Studies at the National Institute of Malariology, Parasitology, and Entomology (NIMPE) of Vietnam. The research received ethical clearance from the NIMPE review board on February 24, 2020 (182/QD-VSR). Written informed consent was obtained from all patients or their legal representatives after receiving an explanation of the study.

This prospective survey was conducted in Nghe An Orthopaedic and Trauma Hospital, Vietnam, between April 2020 and July 2021. Participants were all patients with fractures of the proximal end and agreed to participate in this study. Patients with undisplaced fractures or multisystem trauma were excluded. Participants’ data were collected from the medical records using a standardised case report form. The admission data in this work consisted of demographic variables (gender, age, body mass index (BMI), clinical variables (medical history, comorbidity, type, cause of fractures), laboratory findings (results of blood biochemical tests or cell counts, imaging analysis, bone mineral density (BMD) of the neck of the contralateral femur). Perioperative data included type of surgery (internal fixation or hip arthroplasty (HA), waiting time from the admission to surgery (WTS). The outcome variables were mortality and functional recovery six months post-fractures.

A conventional protocol was applied to all the patients. All comorbidities were treated prior to surgery. Patients with Garden I or II fractures received fixation while partial hip replacements were indicated for fractures of Garden types III and IV. All patients were instructed by rehabilitation specialists to perform in-hospital and at-home functional rehabilitation. The subjects were followed by telephone to determine survival status. The functional outcome was evaluated using Harris hip score (HHS) at six months after the injury12.

The Asian criteria for BMI (Kg/m2) were used to categorise patients (underweight (<18.5), normal weight (18.5 – 23), overweight and obesity (≥23)9. Anaemia was defined as a haemoglobin level below 8.1mmol/L [13 g/dL] in men and below 7.5mmol/L [12g/dL] in women13. The cutoff value for hyperglycemia was random plasma glucose ≥200mg/dL (11.1mmol/L) or fasting plasma glucose ≥126mg/dL (7.0mmol/L)14. Patients having systolic blood pressure (BP) ≥140mm Hg and/or diastolic BP ≥90mm were considered to have raised BP15. The normal ranges of laboratory parameters were as follow: protein 6–8g/dL, albumin 3.5–5.0g/dL, sodium 135–145mmol/L, potassium 3.6–5.0mmol/L, chloride 95–107mmol/L, calcium (total) 2.1–2.6mmol/L, urea 2.5–6.6mmol/L, creatinine 60–120μmol/L16. The C Reactive Protein (CRP) levels were categorised as normal or moderate elevation (≤10.0mg/dL) and marked elevation (>10.0mg/dL)17. Bone mineral density were categorised based on the T-scores as follows: normal (≥-1.0), low bone mass (osteopenia) (-1 to -2.5), or osteoporosis (≤-2.5)18. The cut point for "early" and "delayed" was the operation performed within 48 or after 48 hours of hospital admission, respectively19. Patients with an HHS≤80 were considered to have fair recovery while those with HHS>80 were the good12.

Categorical variables were reported by frequencies and percentages while continuous covariates were expressed as means and standard deviations (SD). Pearson's chi-square tests and, when appropriate, Fisher exact tests were used for univariate analysis. Independent variables that had an association (e.g., p<0.05) on univariate analysis were entered into a multivariable linear regression model to analyse the effect of these variables on mortality and functional outcome. A P value less than 0.05 was considered statistically significant for all analyses. Statistical analysis was performed using SPSS statistical software version 16.0.

Results

There were 118 patients aged between 61 and 101 years (mean of 79.5) included in the study. Among them 66.9% had at least one comorbidity. Hypertension (50.8%) and diabetes mellitus (DM; 40.7%) were the most frequent comorbidities. Coronary artery disease (10.2%), pulmonary disease (7.6%), gastrointestinal disease (4.2%), and neurologic disorders (2.5%) were the other comorbidities reported from our sample. The most frequent cause of the injury was a low-impact fall (95.8%). The most abnormalities in laboratory parameters were the elevation of C-reactive protein (CRP) level, followed by decreased mineral density, anaemia, and hypoalbuminemia. The most common imbalance in electrolyte disorders was decreased sodium levels. Regarding the operation, 67.0% of the patients underwent partial HA, and fixation was indicated for 30.5% of patients.

The minority of patients were female (68.6%), with female: male ratio of 3:1. Compared to males, females had a lower value of BMI, and a higher rate of DM. Females were more likely to suffer from a fracture due to fall, intertrochanteric fracture, and had partial HA. Women had a significantly lower T-score and a higher rate of osteoporosis compared to men. All other findings were nearly comparable in both genders. The 6-month mortality rate was 5.9%. Among 115 survivors there were 66 (59.5%) patients with a good functional recovery (Table I).

Table I:

Clinical and laboratory data of the study population (n=118)

Parameter Value (n, %, CI95% or mean±SD)
Age (years) 79.5±9.4
 ≤ 80 63 (53.4, 44.3 – 62.5)
 > 80 55 (46.6 (37.5 – 55.7)
Gender
 Male 37 (31.4, 21.9 – 40.1)
 Female 81 (68.6, 57.7 – 79.5)
BMI 19.6±1.8
 Underweight 31 (26.3, 17.3 – 35.3)
 Normal weight 82 (69.5, 60.5 – 78.5)
 Overweight and obese 5 (4.2, 0.5 – 7.9)
Comorbidity 79 (66.9, 58.3 – 75.6)
 Hypertension 60 (50.8, 39.8 – 61.8))
 Diabetes mellitus 48 (40.7, 29.7 – 51.6)
Cause of fracture
 Fall 113 (95.8, 86.8 – 104.8)
 Traffic accident 5 (4.2, 0.6 – 7.9)
Type of fracture
 Femoral neck fracture 45 (38.1, 29.1 – 47.1)
 Intertrochanteric fracture 73 (61.9, 52.9 – 70.9)
Laboratory data
 Anemia 96 (81.4, 72.4 – 90.4)
 Low protein 24 (20.3, 11.3 – 29.3)
 Low albumin 78 (66.1, 57.1 – 75.1)
 Normal 20 (16.9, 7.9 – 25.9)
 Osteopenic 54 (45.8, 36.8 – 54.8)
 Osteoporotic 44 (37.3, 28.3 – 46.3)
 Marked elevation of CRP level  83 (70.3, 61.3 – 79.3)
 Elevated ure 39 (33.1, 24.1 – 42.1)
 Elevated creatinin 1 (0.8, -0.8 – 2.5)
 Decreased sodium level 57 (48.3, 39.3 – 57.3)
 Decreased calcium level 32 (27.1, 18.1 – 36.1)
 Decreased potassium level 22 (18.6, 9.6 – 27.6)
 Elevated chloride level 18 (15.3, 6.3 – 24.3)
 Abnormal electrolytes 82 (69.5, 60.5 – 78.5)
WTS (hours) 52.1±33.9
 ≤48 hours 53 (45.8, 36.6 – 54.9)
 >48 hours 65 (54.2, 45.1 – 63.4)
Type of treatment
 No 3 (2.5)
 Fixation 36 (30.5, 21.5 – 39.5)
 Partial HA 79 (67.0, 57.9 – 76.0)
Mortality 7 (5.9, 1.6 – 10.3)
Good function recovery† 66 (55.9, 46.8 – 65.2)

† for 111 survival patiens

The univariate analysis showed that advanced age, hypoproteinemia, and osteoporosis were significantly correlated with mortality. Results of multivariate analysis indicate that advanced age (odds ratio (OR): 3.512, 95% confidence interval 1.538 – 8.019; P<0.001) and hypoproteinemia (OR: 2.859, 95% CI=1.001 – 8.166, P=0.049) were factors significantly predicting 6-month mortality. The mean age was 18.7% higher in the 7 deceased patients than in the 111 survival subjects (93.3±2.9 vs 78.6±8.9 years, P<0.001). No significant correlations between other clinical or laboratory parameters and mortality were found (Table II).

Table II:

Predictor variables of mortality six months after fractures (n=118)

Univariate analysis Multivariate analysis
OR (CI 95%) P OR (CI 95%) P
Age group* 1.083 (1.002 – 1.172) 0.039† 3.512 (1.538 – 8.019) 0.003†
Gender 1.310 (0.600 – 2.860) 0.552
BMI‡ 0.742 (0.321 – 1.713) 0.533
Hypertension 0.941 (0.455 – 1.974) 1.000
Type of fracture 1.129 (0.533 – 2.390) 0.849
BMD§ 2.290 (1.070 – 4.905) 0.036† 1.688 (0.728 – 8.816) 0.223
Diabete mellitus 0.978 (0.467 – 2.051) 1.000
Hypoproteinemia 4.094 (1.545 – 10. 848) 0.005† 2.859 (1.001 – 8.166) 0.049†
Anaemia 0.933 (0.368 – 2.368) 1.000
CRP level|| 1.783 (0.785 – 4.048) 0.233
Hyponatremia 1.489 (0.717 – 3.090) 0.354
Hypokalemia 0.408 (0.147 – 1.131) 0.098
Hypocalcemia 1.169 (0.517 – 2.640) 0.385
Elevated chloride 1.018 (0.371 – 2.796) 1.000
Elevated urea 1.546 (0.714 – 3.346) 0.326
Electrolyte abnormality 0.978 (0.444 – 2.153) 1.000
Waiting time¶ 0.588 (0.281- 1.231) 0.194
Type of surgery# 1.029 (0.475 – 2.230) 1.000

Notes - *Age (≤80 vs >80 years), † significant P<0.05, ‡ underweight patients compared to normal and overweight ones, § comparing between patients with osteoporosis and those with normal or low bone mass (osteopenia), || marked elevation and normal or moderate elevation (≤10 vs >10μmol/L), ¶ ≤48 vs >48 hours, #fixation vs partial HA.

There was a significant association between age and hypoproteinemia with poor outcome of function upon univariable analysis (p<0.05). However, age was the only factor that significantly affected the functional recovery on multivariate analysis. The mean age of patients with good functional outcomes was smaller compared to those with fair outcomes (76.4±8.2 vs 82.8±9.3 years, P<0.001). The average HHS for patients ≤80 years was significantly higher than that among those >80 years (84.2±8.0 vs 75.5±22.2 HHS, P<0.01). No significant association was found between other clinical or laboratory data and functional outcomes (Table III).

Table III:

Factors predicint functional recovery six months after fractures (n=111)

Univariate analysis Multivariate analysis
OR (CI 95%) P OR (CI 95%) P
Age group* 3.788 (1.703 – 8.424) 0.001† 3.167 (1.386 – 7.235) 0.006†
Gender 1.365 (0.607 – 3.069) 0.534
BMI‡ 0.707 (0.293 – 1.707) 0.513
Hypertension 1.176 (0.550 – 2.518) 0.703
Type of fracture 1.439 (0.646 – 3.207) 0.424
BMD§ 1.979 (0.895 – 4.376) 0.107
Comorbitidy 0.871 (0.381 – 1.990) 0.835
Diabete mellitus 0.963 (0.445 – 2.085) 1.000
Hypoproteinemia 3.806 (1.392 – 10.410) 0.012† 2.762 (0.960 – 7.947) 0.060
Hypoalbuminemia 1.501 (0.665 – 3.388) 0.416
Anaemia 0.889 (0.340 – 2.325) 0.810
CRP level|| 1.848 (0.797 – 4.283) 0.215
Hyponatremia 1.458 (0.681 – 3.121) 0.342
Hypokalemia 0.481 (0.172 – 1.343) 0.225
Hypocalcemia 1.171 (0.501 – 2.735) 0.828
Elevated chloride 0.862 (0.289 – 2.565) 1.000
Elevated urea 1.502 (0.672 – 3.357) 0.409
Electrolyte abnormality 1.070 (0.466 – 2.458) 1.000
Waiting time¶ 0.627 (0.291 – 1.351) 0.251
Type of surgery# 1.107 (0.491 – 2.495) 0.839

Notes - *, †, ‡, §, ||, ¶, #: symbols as in Table II. The analysis was done for 111 survival patients only.

Discussion

The first aim of the current study is to find out predictors of six-month mortality in hip fracture patients. Our results demonstrated that advanced age and hypoproteinemia were the independent factors predicting six-month mortality. The list of factors affecting early mortality after hip fracture is very extensive, however, the influence of these factors are variable and, sometimes, conflicting. A number of studies have showed that demographic characteristics such as age4,20,25, gender20-22,24,25, BMI26 are predictors of early mortality in patients with hip fractures. Clinical findings like comorbidities20,23-25,27-29, type of fracture20,28-30, type of surgery20,24, and time until surgery23,24 may also have an effect on early mortality after hip fractures. Similarly, laboratory anormalities including low level of hemoglobin21,31, albumin26,31-34, high levels of ure35, creatinine21,31,35,36, CRP26, sodium35, potassium35 have been found to associated with increased mortality. On the other hand, other reports have found no correlation between gender23,28,29,36, comorbidities26,33, type of fracture37, pre-fracture function29 or laboratory disorders33,34,36,38 and the risk of early mortality among hip fracture patients. The findings of our study reconfirm that advanced age is one of the factors that predict early mortality in elderly patients with hip fractures. Such finding is validated by results from a recent review which showed that age was the only factor influencing mortality risk in all (20/20) studies under reviewed39. The association between hypoproteinemia and increased risk of six-month mortality in our patients is supported by several earlier observations31-34. This association may have a significant clinical implication because hypoproteinemia is a modifiable factor while advanced age is an unmodifiable factor. Measures to control hypoproteinemia such as nutritional supplementation may serve as a key target for peri- and postoperative management to increase survival opportunities for hip fracture patients40. It is interesting to note that the prevalence of overweight in our sample was low (4.2%) compared to reports in developed countries (about 20%)41. However, the difference in bodyweight had no effect on the outcome of the patients which is consistent with those from other studies33.

The second aim of the current study is to identify factors that may predict functional outcomes after hip fractures as mortality and functional status ideally should be considered both together42. Our result shows that advanced age is the only factor that significantly affects the functional recovery of patients with hip fractures (Table III). Many attempts have been made to identify factors predicting functional outcomes, but the results are inconsistent6,23,30,38,43-53. For instance, comorbidity has been found to be a predictor of functional outcome in the studies done by Fox et al (1999)30, Shyu et al (2004)6. On the contrary, Maroffoli et al (1992) found that functional scores six months post-fracture were not significantly different between patients with more than two comorbidities and those having one or no comorbidity45. Slaven EJ (2012) demonstrated that gender was the only individual variable that predicted functional outcomes at six months54, but many other researchers have failed to address the difference in functional outcomes between the two genders23,45,46. The finding of age as the only independent predictor of functional outcome among patients with hip fracture in our study was corroborated by Cornwall R et al (2004)37.

One concern about the findings of our study was that is a small sample and a single-centre study. In addition, the hospital-related factors (such as the type, volume of the hospital) have not been investigated in the current study. Nevertheless, our results can be generalised to elderly patients with hip fractures in other level II centres. The setting in our study is a provincial hospital for trauma and orthopaedics which gives services similar to many level II centres around the world. Our study population is nearly comparable to hip fracture patients worldwide regarding demographic and clinical characteristics (Table I). These similarities suggest that independent factors affecting six-month mortality or functional recovery in our sample could be applicable to other patients suffering from this injury.

Conclusion

This study provided preliminary knowledge concerning pre-and perioperative predictors for mortality and functional outcome following hip fractures in Vietnam. The present study has identified advanced age as an independent predictor of mortality and poor functional outcome as well as figured out the association between hypoproteinemia and mortality after hip fracture. We believe uncovering these data is useful both for providing a precise prognosis and a more adequate intervention strategy (e.g., nutritional supplementation for patients with hypoproteinemia) for hip fracture patients.

Conflict of Interest

The authors declare that there were no conflicts of interest in this study and agree to submit the manuscript for possible for publication.

References

  • 1.Veronese N, Maggi S. Epidemiology and social costs of hip fracture. Injury. 2018;49(8):1458–68. doi: 10.1016/j.injury.2018.04.015. [DOI] [PubMed] [Google Scholar]
  • 2.Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health. 1997;87(3):398–403. doi: 10.2105/ajph.87.3.398. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Diamantopoulos AP, Hoff M, Hochberg M, Haugeberg G. Predictors of short- and long-term mortality in males and females with hip fracture - a prospective observational cohort study. PLoS One. 2013;8(10):e78169. doi: 10.1371/journal.pone.0078169. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.LeBlanc ES, Hillier TA, Pedula KL, Rizzo JH, Cawthon PM, Fink HA et al. Hip fracture and increased short-term but not longterm mortality in healthy older women. Arch Intern Med. 2011;171(20):1831–7. doi: 10.1001/archinternmed.2011.447. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zuckerman J, Koval K, Aharonoff G, Skovron M. A functional recovery score for elderly hip fracture patients: II. Validity and reliability. J Orthop Trauma. 2000;14(1):26–30. doi: 10.1097/00005131-200001000-00006. doi: [DOI] [PubMed] [Google Scholar]
  • 6.Shyu Y, Chen M, Liang J, Wu C, Su J. Predictors of functional recovery for hip fractured elders during 12 months following hospital discharge: a prospective study on a Taiwanese sample. Osteoporos Int. 2004;15(6):475–482. doi: 10.1007/s00198-003-1557-2. doi: [DOI] [PubMed] [Google Scholar]
  • 7.Handong L, Hongngoc N, Tianmin Z. Vietnam’s Population Projections, Aging Trends from. to 2049. Popul Ageing. 2010;2021;14:165–82. doi: 10.1007/s12062-019-09257-3. doi: [DOI] [Google Scholar]
  • 8.Tuan N, Tuong P, Popkin B. Body mass index (BMI) dynamics in Vietnam. Eur J Clin Nutr. 2008;62:78–86. doi: 10.1038/sj.ejcn.1602675. doi: [DOI] [PubMed] [Google Scholar]
  • 9.Consultation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63. doi: 10.1016/S0140-6736(03)15268-3. doi: [DOI] [PubMed] [Google Scholar]
  • 10.Xuan T, Trung D, Gia D, Minh D. Changes of the serum creatine phosphokinase in total hip arthroplasty in Vietnamese patients. J Arthrosc Jt Surg. 2018;6(3):180–183. doi: 10.1016/j.jajs.2018.11.005. doi: [DOI] [Google Scholar]
  • 11.Dung T, Trung H, Tran Quang S, Hoang T, Van K. Evaluation of the result of total hip arthroplasty with minimally invasive surgery for fracture of femoral neck caused by trauma in Vietnamese adult. Ann Musculoskelet Med. 2017;1(2):43–5. [Google Scholar]
  • 12.Harris W. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Jt Surg Am. 1969;51(4):737–55. [PubMed] [Google Scholar]
  • 13.World Health Organization (WHO). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva. 2011. https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf (accessed on 27 August 2021)
  • 14.American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–31. doi: 10.2337/dc20-S002. doi: [DOI] [PubMed] [Google Scholar]
  • 15.World Health Organization (WHO): Noncommunicable diseases: Hypertension. 2015. https://www.who.int/news-room/questions-and-answers/item/noncommunicable-diseases-hypertension (accessed on 27 August 2021)
  • 16.Walker BR, Colledge NR, Ralston SH, Penman ID. 2014. p. 1392. editors. Davidson’s Principles and Practice of Medicine. 22nd ed. Churchill Livingstone, Elsevier;
  • 17.Nehring SM, Goyal A, Patel BC. StatPearls. Treasure Island (FL): StatPearls Publishing; C Reactive Protein. 2022 Jul 18. 2022 Jan. [PubMed] [Google Scholar]
  • 18.Lewiecki EM. Endotext. South Dartmouth (MA): 2000. Osteoporosis: Clinical Evaluation. 2021 Jun 7. In:MDText.com, Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Inc. [Google Scholar]
  • 19.Ryan DJ, Yoshihara H, Yoneoka D, Egol KA, Zuckerman JD. Delay in Hip Fracture Surgery: An Analysis of Patient-Specific and Hospital-Specific Risk Factors. J Orthop Trauma. 2015;29(8):343–8. doi: 10.1097/BOT.0000000000000313. doi: [DOI] [PubMed] [Google Scholar]
  • 20.Bergh C, Moller M, Ekelund J, Brisby H. 30-day and 1-year mortality after skeletal fractures: a register study of 295,713 fractures at different locations. Acta Orthop. 2021. pp. 1–7. doi: [DOI] [PMC free article] [PubMed]
  • 21.Bjorkelund K, Hommel A, Thorngren K, Lundberg D, Larsson S. Factors at admission associated with 4 months outcome in elderly patients with hip fracture. AANA J. 2009;77(1):49–58. [PubMed] [Google Scholar]
  • 22.Soderqvist A, Ekstrom W, Ponzer S, Petterson H, Cederholm T, Dalen N et al. Prediction of mortality in elderly patients with hip fractures: a two-year prospective study of 1,944 patients. Gerontology. 2009;55(5):496–504. doi: 10.1159/000230587. doi: [DOI] [PubMed] [Google Scholar]
  • 23.Maggi S, Siviero P, Wetle T, Besdine R, Saugo M, Crepaldi G. A multicenter survey on profile of care for hip fracture: predictors of mortality and disability. Osteoporos Int. 2010;21(2):223–31. doi: 10.1007/s00198-009-0936-8. doi: [DOI] [PubMed] [Google Scholar]
  • 24.Rosso F, Dettoni F, Bonasia DE, Olivero F, Mattei L, Bruzzone M et al. Prognostic factors for mortality after hip fracture: Operation within 48 hours is mandatory. Injury. 2016;47(Suppl 4):S91–7. doi: 10.1016/j.injury.2016.07.055. doi: [DOI] [PubMed] [Google Scholar]
  • 25.Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE. Survival experience of aged hip fracture patients. Am J Public Health. 1989;79(3):274–8. doi: 10.2105/ajph.79.3.274. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kim BG, Lee YK, Park HP, Sohn HM, Oh AY, Jeon YT et al. C-reactive protein is an independent predictor for 1-year mortality in elderly patients undergoing hip fracture surgery: A retrospective analysis. Medicine (Baltimore). 2016;95(43):e5152. doi: 10.1097/MD.0000000000005152. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gonzalez-Zabaleta J, Pita-Fernandez S, Seoane-Pillado T, Lopez-Calvino B, Gonzalez-Zabaleta J. Comorbidity as a predictor of mortality and mobility after hip fracture. Geriatr Gerontol Int. 2016;16(5):561–9. doi: 10.1111/ggi.12510.. doi: [DOI] [PubMed] [Google Scholar]
  • 28.Prodovic T, Ristic B, Rancic N, Bukumiric Z, Zeljko S, Ignjatovic-Ristic D. Factors Influencing The Six-Month Mortality Rate In Patients With A Hip Fracture: Dejavniki, Ki Vplivajo Na Šestmesečno Stopnjo Umrljivosti Pri Bolnikih Z Zlomom Kolka. Zdr Varst. 2016;55(2):102–7. doi: 10.1515/sjph-2016-0015. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Marottoli RA, Berkman LF, Leo-Summers L. Cooney Jr LM. Predictors of mortality and institutionalization after hip fracture: the New Haven EPESE cohort. Established Populations for Epidemiologic Studies of the Elderly. Am J Public Health. 1994;84(11):1807–12. doi: 10.2105/ajph.84.11.1807. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fox KM, Magaziner J, Hebel JR, Kenzora JE, Kashner TM. Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment, and sequelae. J Gerontol A Biol Sci Med Sci. 1999;54(12):M635–40. doi: 10.1093/gerona/54.12.m635. doi: [DOI] [PubMed] [Google Scholar]
  • 31.Laulund AS, Lauritzen JB, Duus BR, Mosfeldt M, Jorgensen HL. Routine blood tests as predictors of mortality in hip fracture patients. Injury. 2012;43(7):1014–20. doi: 10.1016/j.injury.2011.12.008. doi: [DOI] [PubMed] [Google Scholar]
  • 32.Wang Y, Li X, Ji Y, Tiang H, Liang X, Li N et al. Preoperative Serum Albumin Level As A Predictor Of Postoperative Pneumonia After Femoral Neck Fracture Surgery In A Geriatric Population. Clin Interv Aging. 2019;14:2007–16. doi: 10.2147/CIA.S231736. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Higashikawa T, Shigemoto K, Goshima K, Horri T, Usuda D, Morita T et al. Mortality and the Risk Factors in Elderly Female Patients With Femoral Neck and Trochanteric Fractures. J Clin Med Res. 2020;12(10):668–73. doi: 10.14740/jocmr4292. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lu J, Chen Y, Zhang L, Li Y, Wang C. Laboratory nutritional parameters predict one-year mortality in elderly patients with intertrochanteric fracture. Asia Pac J Clin Nutr. 2016;25(3):457–63. doi: 10.6133/apjcn.092015.04. doi: [DOI] [PubMed] [Google Scholar]
  • 35.Lewis JR, Hassan SKZ, Wenn RT, Moran CG. Mortality and serum urea and electrolytes on admission for hip fracture patients. Injury. 2006;37(8):698–704. doi: 10.1016/j.injury.2006.04.121. doi: [DOI] [PubMed] [Google Scholar]
  • 36.Seyedi HR, Mahdian M, Khosravi G, Bidgoli MS, Mousavi SG, Razavizadeh MR et al. Prediction of mortality in hip fracture patients: role of routine blood tests. Arch bone Jt Surg. 2015;3(1):51–5. [PMC free article] [PubMed] [Google Scholar]
  • 37.Cornwall R, Gilbert MS, Koval KJ, Strauss E, Siu AL. Functional outcomes and mortality vary among different types of hip fractures: a function of patient characteristics. Clin Orthop Relat Res. 2004. pp. 64–71. doi: [DOI] [PMC free article] [PubMed]
  • 38.Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J et al. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004;18(6):369–74. doi: 10.1097/00005131200407000-00007. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Xu BY, Yan S, Low LL, Vasanwala FF, Low SG. Predictors of poor functional outcomes and mortality in patients with hip fracture: a systematic review. BMC Musculoskelet Disord. 2019;20(1):568. doi: 10.1186/s12891-019-2950-0. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Delmi M, Rapin CH, Bengoa JM, Bonjour JP, Vasey H, Delmas PD. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet. 1990;335(8696):1013–6. doi: 10.1016/0140-6736(90)91073-J. doi: [DOI] [PubMed] [Google Scholar]
  • 41.Chan M, Frost S, Center J, Eisman J, Nguyen T. Relationship between body mass index and fracture risk is mediated by bone mineral density. J Bone Min Res. 2014;29(11):2327–35. doi: 10.1002/jbmr.2288. doi: [DOI] [PubMed] [Google Scholar]
  • 42.Hannan EL, Magaziner J, Wang JJ, Eastwood EA, Silberzweig SB, Gilbert M et al. Mortality and Locomotion 6 Months After Hospitalization for Hip FractureRisk Factors and Risk-Adjusted Hospital Outcomes. JAMA. 2001;285(21):2736–42. doi: 10.1001/jama.285.21.2736. doi: [DOI] [PubMed] [Google Scholar]
  • 43.Buecking B, Bohl K, Eschbach D, Bliemel C, Aigner R, Balzer-Geldsetzer M et al. Factors influencing the progress of mobilization in hip fracture patients during the early postsurgical period?-A prospective observational study. Arch Gerontol Geriatr. 2015;60(3):457–63. doi: 10.1016/j.archger.2015.01.017. doi: [DOI] [PubMed] [Google Scholar]
  • 44.Doshi H, Ramason R, Azellarasi J, Chan W, Naidu G. Functional improvement of self-care in the elderly after hip fracture: is age a factor? Arch Orthop Trauma Surg. 2014;134(4):489–93. doi: 10.1007/s00402-014-1924-9. doi: [DOI] [PubMed] [Google Scholar]
  • 45.Marottoli R, Berkman L, Cooney LJ. Decline in physical function following hip fracture. J Am Geriatr Soc. 1992;40(9):861–6. doi: 10.1111/j.1532-5415.1992.tb01980.x. doi: [DOI] [PubMed] [Google Scholar]
  • 46.Fantini M, Fabbri G, Laus M, Carretta E, Mimmi S, Franchino G et al. Determinants of surgical delay for hip fracture. Surgeon. 2011;9(3):130–4. doi: 10.1016/j.surge.2010.11.031. doi: [DOI] [PubMed] [Google Scholar]
  • 47.Mizrahi E, Fleissig Y, Arad M, Blumstein T, Adunsky A. Admission albumin levels and functional outcome of elderly hip fracture patients: is it that important? Aging Clin Exp Res. 2007;19(4):284–289. doi: 10.1007/BF03324703. doi: [DOI] [PubMed] [Google Scholar]
  • 48.Kalu ME, Ojembe BU, Akinrolie O, Okoh AC, Adandom II, Nwankwo HC et al. Setting priorities for ageing research in Africa: A systematic mapping review of 512 studies from sub-Saharan Africa. J Glob Health. 2021;11:15002. doi: 10.7189/11.15002. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Dubljanin-Raspopovic E, Markovic-Denic L, Nikolic D, Tulic G, Kadija M, Bumbasirevic M. Is anemia at admission related to short-term outcomes of elderly hip fracture patients? Open Med. 2011;6(4):483–9. doi: 10.2478/s11536-011-0031-3. doi: [DOI] [Google Scholar]
  • 50.Sheehan K, Williamson L, Alexander J, Filliter C, Sobolev B, Guy P et al. Prognostic factors of functional outcome after hip fracture surgery: a systematic review. Age Ageing. 2018;47(5):661–70. doi: 10.1093/ageing/afy057. doi: [DOI] [PubMed] [Google Scholar]
  • 51.Goisser S, Schrader E, Singler K, Bertsch T, Gefeller O, Biber R et al. Malnutrition According to Mini Nutritional Assessment Is Associated With Severe Functional Impairment in Geriatric Patients Before and up to 6 Months After Hip Fracture. J Am Med Dir Assoc. 2015;16(8):661–667. doi: 10.1016/j.jamda.2015.03.002. doi: [DOI] [PubMed] [Google Scholar]
  • 52.Adunsky A, Mizrahi E, Kaplan A, Purits E, Waitzman A, Arad M. Elevated blood urea, independent of glomerular filtration rate (GFR), confers increased risk of adverse functional outcome in elderly hip fracture patients. Arch Gerontol Geriatr. 2011;53(2):e174–8. doi: 10.1016/j.archger.2010.08.009. doi: [DOI] [PubMed] [Google Scholar]
  • 53.Orosz GM, Magaziner J, Hannan EL, Morrison RS, Koval K, Gilbert M et al. Association of timing of surgery for hip fracture and patient outcomes. JAMA. 2004;291(14):1738–1743. doi: 10.1001/jama.291.14.1738. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Slaven EJ. Prediction of functional outcome at six months following total hip arthroplasty. Phys Ther. 2012;92(11):1386–94. doi: 10.2522/ptj.20110484. doi: [DOI] [PubMed] [Google Scholar]

Articles from Malaysian Orthopaedic Journal are provided here courtesy of Malaysian Orthopedic Association

RESOURCES